Cascadian Therapeutics Inc (USA) Stock

Stocks

18-01-04	Cascadian Therapeutics Announces 2018 Outlook and Recent Progress	GL
18-01-02	Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines Agency	GL
17-12-13	Cascadian Therapeutics Added to the Nasdaq Biotechnology Index	GL
17-12-07	Prolonged Progression-Free Survival Reinforces Tucatinib’s Potential for Patients with Advanced HER2+ Metastatic Breast Cancer	GL
17-11-08	Cascadian Therapeutics Reports Third Quarter 2017 Financial Results	GL

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CASCADIAN THERAPEUTICS INC (USA)	-.--%	+0.50%	-	-	0
WUXI APPTEC CO., LTD.	+0.88%	+1.18%	+40.64%	+74.91%	64.69B
ARGENX SE	-0.26%	+7.23%	+11.14%	+74.78%	54.78B
LONZA GROUP AG	+0.47%	+3.52%	+9.71%	+100.95%	53.49B
IQVIA HOLDINGS INC.	-2.06%	+2.90%	+25.83%	+48.36%	45.98B
BEONE MEDICINES AG	-1.79%	+0.19%	+17.58%	+123.62%	42.94B
REVOLUTION MEDICINES, INC.	-1.65%	+0.96%	+217.12%	+823.66%	40.08B
CELLTRION, INC.	-2.26%	-2.06%	+15.38%	+45.14%	33.52B
WUXI BIOLOGICS (CAYMAN) INC.	+0.22%	-4.77%	+26.59%	+0.55%	23.97B
GENMAB A/S	+12.10%	+16.60%	+58.50%	+46.15%	23.67B
Average	+0.56%	+2.22%	+46.94%	+148.68%	42.57B
Weighted average by Cap.	+0.12%	+2.59%	+44.22%	+150.09%

Employees

Sector